Medical News

RSS

New study strengthens the link between sleep-disordered breathing and gestational diabetes

Sleep-disordered breathing in early pregnancy is associated with insulin resistance or difficulty clearing glucose from the blood, suggests a small study funded by the National Institutes of Health.

6 Jan 2022

Salk professor receives $1.2 million from Larry L. Hillblom Foundation for diabetes research

Professor Ronald Evans will receive $1.2 million over four years as part of a Network Grant from the Larry L. Hillblom Foundation to examine a molecular pathway that regulates blood sugar and fat independent of insulin.

6 Jan 2022

KHN’s ‘What the Health?’: Contagion confusion

The covid-19 pandemic is now entering its third year, and the ever-evolving health advice to combat an ever-evolving virus is leaving Americans more cranky and confused than ever.

6 Jan 2022

Researchers create new monoclonal antibody treatment effective against both Delta and Omicron

In a new study, researchers conducted surface plasmon resonance experiments using commercially sourced SARS-CoV-2 protein reagents.

6 Jan 2022

Study suggests that previous COVID-19 infections do not affect pregnancy

A new study shows that it is exceedingly likely that past infection with SARS-CoV-2 has no significant effect on antibody or cytokine levels during pregnancy, labor or delivery.

6 Jan 2022

Researchers outline characteristics of Omicron variant immune escape and viral entry into host cells

A new study found that the Omicron variant contains a number of mutations that decrease neutralizing antibody activity and immune escape.

6 Jan 2022

Study identifies current mechanism of action behind reduced severity of Omicron variant COVID-19 infection

New research shows evidence that the Omicron variant is less severe compared to the Delta variant.

6 Jan 2022

More is better than less when it comes to physical activity and cardiovascular disease

In this interview, we speak to Esmée Bakker about her latest research which investigated the impact physical activity has on cardiovascular disease.

6 Jan 2022

Emergence of a new SARS-CoV-2 variant from Southern France

A new study has described the emergence of another new SARS-CoV-2 variant from south-eastern France with Cameroonian origin.

6 Jan 2022

Small molecule identified as a SARS-CoV-2 inhibitor

A new study published in iScience reports the results of a screening strategy to identify small molecules that target viral entry to block infection with this virus.

6 Jan 2022

Emotional response can fuel the spread of "fake news"

From Facebook feeds to questionable websites, so-called "fake news" is seemingly everywhere. When it comes to the misleading information, our emotional response to seeing it can actually further its spread, according to a Bowling Green State University researcher.

6 Jan 2022

Host kinase identified as an inhibition target for SARS-CoV-2

In this experiment, the chemical probe SGC-CK2-1 inhibited virus replication at nanomolar concentration, showing a highly selective effect on the kinase.

6 Jan 2022

New drug targeting LF and onchocerciasis begins its first in human trial in Liverpool

A new drug developed by an LSTM led partnership, which targets the neglected tropical diseases lymphatic filariasis and onchocerciasis has begun its first in human trial.

6 Jan 2022

Exploring a micro-simulation study on shielding individuals at high risk of COVID-19

A new study used an individual-based mathematical model to simulate the evolution of COVID-19 in a population, where a fraction of high-risk individuals is relocated to shielding residences having varying degrees of contact with others.

6 Jan 2022

Serological antibody response to SARS-CoV-2 infection at a population level

The scientists in this study used pooled convalescent serum to examine the serologic response in a population at risk of infection.

6 Jan 2022

Study finds all three proteins required for SARS-CoV-2 infection present in human glossopharyngeal and vagal nerves

Researchers explored the presence of coronavirus receptors in the glossopharyngeal and vagal cranial nerves.

6 Jan 2022

Melatonin found to inhibit SARS-CoV-2 entry into mice brains

New research recently unveiled the utility of melatonin and melatonin-derived medicines in reducing brain entry of severe acute respiratory syndrome coronavirus 2 and subsequently preventing long-term neurological consequences of coronavirus disease 2019.

6 Jan 2022

Medical News

New study strengthens the link between sleep-disordered breathing and gestational diabetes

Salk professor receives $1.2 million from Larry L. Hillblom Foundation for diabetes research

KHN’s ‘What the Health?’: Contagion confusion

Researchers create new monoclonal antibody treatment effective against both Delta and Omicron

Study suggests that previous COVID-19 infections do not affect pregnancy

Researchers outline characteristics of Omicron variant immune escape and viral entry into host cells

Study identifies current mechanism of action behind reduced severity of Omicron variant COVID-19 infection

More is better than less when it comes to physical activity and cardiovascular disease

Emergence of a new SARS-CoV-2 variant from Southern France

Small molecule identified as a SARS-CoV-2 inhibitor

Emotional response can fuel the spread of "fake news"

Host kinase identified as an inhibition target for SARS-CoV-2

New drug targeting LF and onchocerciasis begins its first in human trial in Liverpool

Exploring a micro-simulation study on shielding individuals at high risk of COVID-19

Serological antibody response to SARS-CoV-2 infection at a population level

Study finds all three proteins required for SARS-CoV-2 infection present in human glossopharyngeal and vagal nerves

Melatonin found to inhibit SARS-CoV-2 entry into mice brains

The war on cancer at 50: The origin story begins with a socialite citizen-lobbyist

South Dakota voters to decide Medicaid expansion

A new paradigm is needed: Top experts question the value of advance care planning

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News